Copyright Reports & Markets. All rights reserved.

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Equine Pharmaceuticals and Supplements Market 2018, Forecast to 2023

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Equine Pharmaceuticals and Supplements Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Pharmaceuticals
      • 1.2.2 Supplements
    • 1.3 Market Analysis by Applications
      • 1.3.1 Veterinary Hospitals
      • 1.3.2 Drug Stores
      • 1.3.3 Others
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2013-2023)
        • 1.4.1.2 Canada Market States and Outlook (2013-2023)
        • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2013-2023)
        • 1.4.2.2 France Market States and Outlook (2013-2023)
        • 1.4.2.3 UK Market States and Outlook (2013-2023)
        • 1.4.2.4 Russia Market States and Outlook (2013-2023)
        • 1.4.2.5 Italy Market States and Outlook (2013-2023)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2013-2023)
        • 1.4.3.2 Japan Market States and Outlook (2013-2023)
        • 1.4.3.3 Korea Market States and Outlook (2013-2023)
        • 1.4.3.4 India Market States and Outlook (2013-2023)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
        • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
        • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
        • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Affymetrix
      • 2.1.1 Business Overview
        • 2.1.1.1 Affymetrix Description
        • 2.1.1.2 Affymetrix Headquarter, Main Business and Finance Overview
      • 2.1.2 Affymetrix Equine Pharmaceuticals and Supplements Product Introduction
        • 2.1.2.1 Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
        • 2.1.2.2 Equine Pharmaceuticals and Supplements Product Information
      • 2.1.3 Affymetrix Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.1.3.1 Affymetrix Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.1.3.2 Global Affymetrix Equine Pharmaceuticals and Supplements Market Share in 2017
    • 2.2 Bayer Animal Health
      • 2.2.1 Business Overview
        • 2.2.1.1 Bayer Animal Health Description
        • 2.2.1.2 Bayer Animal Health Headquarter, Main Business and Finance Overview
      • 2.2.2 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Introduction
        • 2.2.2.1 Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
        • 2.2.2.2 Equine Pharmaceuticals and Supplements Product Information
      • 2.2.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.2.3.1 Bayer Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.2.3.2 Global Bayer Animal Health Equine Pharmaceuticals and Supplements Market Share in 2017
    • 2.3 Boehringer Ingelheim
      • 2.3.1 Business Overview
        • 2.3.1.1 Boehringer Ingelheim Description
        • 2.3.1.2 Boehringer Ingelheim Headquarter, Main Business and Finance Overview
      • 2.3.2 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Introduction
        • 2.3.2.1 Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
        • 2.3.2.2 Equine Pharmaceuticals and Supplements Product Information
      • 2.3.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.3.3.1 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.3.3.2 Global Boehringer Ingelheim Equine Pharmaceuticals and Supplements Market Share in 2017
    • 2.4 Celltrion Inc
      • 2.4.1 Business Overview
        • 2.4.1.1 Celltrion Inc Description
        • 2.4.1.2 Celltrion Inc Headquarter, Main Business and Finance Overview
      • 2.4.2 Celltrion Inc Equine Pharmaceuticals and Supplements Product Introduction
        • 2.4.2.1 Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
        • 2.4.2.2 Equine Pharmaceuticals and Supplements Product Information
      • 2.4.3 Celltrion Inc Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.4.3.1 Celltrion Inc Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.4.3.2 Global Celltrion Inc Equine Pharmaceuticals and Supplements Market Share in 2017
    • 2.5 Elanco Animal Health
      • 2.5.1 Business Overview
        • 2.5.1.1 Elanco Animal Health Description
        • 2.5.1.2 Elanco Animal Health Headquarter, Main Business and Finance Overview
      • 2.5.2 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Introduction
        • 2.5.2.1 Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
        • 2.5.2.2 Equine Pharmaceuticals and Supplements Product Information
      • 2.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.5.3.1 Elanco Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.5.3.2 Global Elanco Animal Health Equine Pharmaceuticals and Supplements Market Share in 2017
    • 2.6 Merck Animal Health
      • 2.6.1 Business Overview
        • 2.6.1.1 Merck Animal Health Description
        • 2.6.1.2 Merck Animal Health Headquarter, Main Business and Finance Overview
      • 2.6.2 Merck Animal Health Equine Pharmaceuticals and Supplements Product Introduction
        • 2.6.2.1 Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
        • 2.6.2.2 Equine Pharmaceuticals and Supplements Product Information
      • 2.6.3 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.6.3.1 Merck Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.6.3.2 Global Merck Animal Health Equine Pharmaceuticals and Supplements Market Share in 2017
    • 2.7 Merial
      • 2.7.1 Business Overview
        • 2.7.1.1 Merial Description
        • 2.7.1.2 Merial Headquarter, Main Business and Finance Overview
      • 2.7.2 Merial Equine Pharmaceuticals and Supplements Product Introduction
        • 2.7.2.1 Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
        • 2.7.2.2 Equine Pharmaceuticals and Supplements Product Information
      • 2.7.3 Merial Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.7.3.1 Merial Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.7.3.2 Global Merial Equine Pharmaceuticals and Supplements Market Share in 2017
    • 2.8 Novartis Animal Health
      • 2.8.1 Business Overview
        • 2.8.1.1 Novartis Animal Health Description
        • 2.8.1.2 Novartis Animal Health Headquarter, Main Business and Finance Overview
      • 2.8.2 Novartis Animal Health Equine Pharmaceuticals and Supplements Product Introduction
        • 2.8.2.1 Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
        • 2.8.2.2 Equine Pharmaceuticals and Supplements Product Information
      • 2.8.3 Novartis Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.8.3.1 Novartis Animal Health Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.8.3.2 Global Novartis Animal Health Equine Pharmaceuticals and Supplements Market Share in 2017
    • 2.9 Vetoquinol
      • 2.9.1 Business Overview
        • 2.9.1.1 Vetoquinol Description
        • 2.9.1.2 Vetoquinol Headquarter, Main Business and Finance Overview
      • 2.9.2 Vetoquinol Equine Pharmaceuticals and Supplements Product Introduction
        • 2.9.2.1 Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
        • 2.9.2.2 Equine Pharmaceuticals and Supplements Product Information
      • 2.9.3 Vetoquinol Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.9.3.1 Vetoquinol Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.9.3.2 Global Vetoquinol Equine Pharmaceuticals and Supplements Market Share in 2017
    • 2.10 Zoetis
      • 2.10.1 Business Overview
        • 2.10.1.1 Zoetis Description
        • 2.10.1.2 Zoetis Headquarter, Main Business and Finance Overview
      • 2.10.2 Zoetis Equine Pharmaceuticals and Supplements Product Introduction
        • 2.10.2.1 Equine Pharmaceuticals and Supplements Production Bases, Sales Regions and Major Competitors
        • 2.10.2.2 Equine Pharmaceuticals and Supplements Product Information
      • 2.10.3 Zoetis Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.10.3.1 Zoetis Equine Pharmaceuticals and Supplements Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
        • 2.10.3.2 Global Zoetis Equine Pharmaceuticals and Supplements Market Share in 2017

      3 Global Equine Pharmaceuticals and Supplements Market Competition, by Manufacturer

      • 3.1 Global Equine Pharmaceuticals and Supplements Sales and Market Share by Manufacturer (2016-2017)
      • 3.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Manufacturer (2016-2017)
      • 3.3 Global Equine Pharmaceuticals and Supplements Price by Manufacturer (2016-2017)
      • 3.4 Market Concentration Rate
        • 3.4.1 Top 3 Equine Pharmaceuticals and Supplements Manufacturer Market Share in 2017
        • 3.4.2 Top 5 Equine Pharmaceuticals and Supplements Manufacturer Market Share in 2017
      • 3.5 Market Competition Trend

      4 Global Equine Pharmaceuticals and Supplements Market Analysis by Regions

      • 4.1 Global Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Regions
        • 4.1.1 Global Equine Pharmaceuticals and Supplements Sales by Regions (2013-2018)
        • 4.1.2 Global Equine Pharmaceuticals and Supplements Revenue by Regions (2013-2018)
      • 4.2 North America Equine Pharmaceuticals and Supplements Sales, Revenue and Growth Rate (2013-2018)
      • 4.3 Europe Equine Pharmaceuticals and Supplements Sales, Revenue and Growth Rate (2013-2018)
      • 4.4 Asia-Pacific Equine Pharmaceuticals and Supplements Sales, Revenue and Growth Rate (2013-2018)
      • 4.5 South America Equine Pharmaceuticals and Supplements Sales, Revenue and Growth Rate (2013-2018)
      • 4.6 Middle East and Africa Equine Pharmaceuticals and Supplements Sales, Revenue and Growth Rate (2013-2018)

      5 North America Equine Pharmaceuticals and Supplements by Countries, Type, Application and Manufacturers

      • 5.1 North America Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Countries
        • 5.1.1 North America Equine Pharmaceuticals and Supplements Sales by Countries (2013-2018)
        • 5.1.2 North America Equine Pharmaceuticals and Supplements Revenue by Countries (2013-2018)
        • 5.1.3 United States Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
        • 5.1.4 Canada Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
        • 5.1.5 Mexico Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
      • 5.2 North America Equine Pharmaceuticals and Supplements Sales and Revenue (Value) by Manufacturers (2016-2017)
        • 5.2.1 North America Equine Pharmaceuticals and Supplements Sales by Manufacturers (2016-2017)
        • 5.2.2 North America Equine Pharmaceuticals and Supplements Revenue by Manufacturers (2016-2017)
      • 5.3 North America Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Type (2013-2018)
        • 5.3.1 North America Equine Pharmaceuticals and Supplements Sales and Sales Share by Type (2013-2018)
        • 5.3.2 North America Equine Pharmaceuticals and Supplements Revenue and Revenue Share by Type (2013-2018)
      • 5.4 North America Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Application (2013-2018)
        • 5.4.1 North America Equine Pharmaceuticals and Supplements Sales and Sales Share by Application (2013-2018)
        • 5.4.2 North America Equine Pharmaceuticals and Supplements Revenue and Revenue Share by Application (2013-2018)

      6 Europe Equine Pharmaceuticals and Supplements by Countries, Type, Application and Manufacturers

      • 6.1 Europe Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Countries
        • 6.1.1 Europe Equine Pharmaceuticals and Supplements Sales by Countries (2013-2018)
        • 6.1.2 Europe Equine Pharmaceuticals and Supplements Revenue by Countries (2013-2018)
        • 6.1.3 Germany Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
        • 6.1.4 UK Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
        • 6.1.5 France Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
        • 6.1.6 Russia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
        • 6.1.7 Italy Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
      • 6.2 Europe Equine Pharmaceuticals and Supplements Sales and Revenue (Value) by Manufacturers (2016-2017)
        • 6.2.1 Europe Equine Pharmaceuticals and Supplements Sales by Manufacturers (2016-2017)
        • 6.2.2 Europe Equine Pharmaceuticals and Supplements Revenue by Manufacturers (2016-2017)
      • 6.3 Europe Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Type (2013-2018)
        • 6.3.1 Europe Equine Pharmaceuticals and Supplements Sales and Sales Share by Type (2013-2018)
        • 6.3.2 Europe Equine Pharmaceuticals and Supplements Revenue and Revenue Share by Type (2013-2018)
      • 6.4 Europe Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Application (2013-2018)
        • 6.4.1 Europe Equine Pharmaceuticals and Supplements Sales and Sales Share by Application (2013-2018)
        • 6.4.2 Europe Equine Pharmaceuticals and Supplements Revenue and Revenue Share by Application (2013-2018)

      7 Asia-Pacific Equine Pharmaceuticals and Supplements by Countries, Type, Application and Manufacturers

      • 7.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Countries
        • 7.1.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Countries (2013-2018)
        • 7.1.2 Asia-Pacific Equine Pharmaceuticals and Supplements Revenue by Countries (2013-2018)
        • 7.1.3 China Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
        • 7.1.4 Japan Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
        • 7.1.5 Korea Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
        • 7.1.6 India Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
        • 7.1.7 Southeast Asia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
      • 7.2 Asia-Pacific Equine Pharmaceuticals and Supplements Sales and Revenue (Value) by Manufacturers (2016-2017)
        • 7.2.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales by Manufacturers (2016-2017)
        • 7.2.2 Asia-Pacific Equine Pharmaceuticals and Supplements Revenue by Manufacturers (2016-2017)
      • 7.3 Asia-Pacific Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Type (2013-2018)
        • 7.3.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales and Sales Share by Type (2013-2018)
        • 7.3.2 Asia-Pacific Equine Pharmaceuticals and Supplements Revenue and Revenue Share by Type (2013-2018)
      • 7.4 Asia-Pacific Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Application (2013-2018)
        • 7.4.1 Asia-Pacific Equine Pharmaceuticals and Supplements Sales and Sales Share by Application (2013-2018)
        • 7.4.2 Asia-Pacific Equine Pharmaceuticals and Supplements Revenue and Revenue Share by Application (2013-2018)

      8 South America Equine Pharmaceuticals and Supplements by Countries, Type, Application and Manufacturers

      • 8.1 South America Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Countries
        • 8.1.1 South America Equine Pharmaceuticals and Supplements Sales by Countries (2013-2018)
        • 8.1.2 South America Equine Pharmaceuticals and Supplements Revenue by Countries (2013-2018)
        • 8.1.3 Brazil Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
        • 8.1.4 Argentina Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
        • 8.1.5 Colombia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
      • 8.2 South America Equine Pharmaceuticals and Supplements Sales and Revenue (Value) by Manufacturers (2016-2017)
        • 8.2.1 South America Equine Pharmaceuticals and Supplements Sales by Manufacturers (2016-2017)
        • 8.2.2 South America Equine Pharmaceuticals and Supplements Revenue by Manufacturers (2016-2017)
      • 8.3 South America Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Type (2013-2018)
        • 8.3.1 South America Equine Pharmaceuticals and Supplements Sales and Sales Share by Type (2013-2018)
        • 8.3.2 South America Equine Pharmaceuticals and Supplements Revenue and Revenue Share by Type (2013-2018)
      • 8.4 South America Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Application (2013-2018)
        • 8.4.1 South America Equine Pharmaceuticals and Supplements Sales and Sales Share by Application (2013-2018)
        • 8.4.2 South America Equine Pharmaceuticals and Supplements Revenue and Revenue Share by Application (2013-2018)

      9 Middle East and Africa Equine Pharmaceuticals and Supplements by Countries, Type, Application and Manufacturers

      • 9.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Countries
        • 9.1.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Countries (2013-2018)
        • 9.1.2 Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Countries (2013-2018)
        • 9.1.3 Saudi Arabia Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
        • 9.1.4 UAE Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
        • 9.1.5 Egypt Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
        • 9.1.6 Nigeria Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
        • 9.1.7 South Africa Equine Pharmaceuticals and Supplements Sales and Growth Rate (2013-2018)
      • 9.2 Middle East and Africa Equine Pharmaceuticals and Supplements Sales and Revenue (Value) by Manufacturers (2016-2017)
        • 9.2.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales by Manufacturers (2016-2017)
        • 9.2.2 Middle East and Africa Equine Pharmaceuticals and Supplements Revenue by Manufacturers (2016-2017)
      • 9.3 Middle East and Africa Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Type (2013-2018)
        • 9.3.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales and Sales Share by Type (2013-2018)
        • 9.3.1 Middle East and Africa Equine Pharmaceuticals and Supplements Revenue and Revenue Share by Type (2013-2018)
      • 9.4 Middle East and Africa Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Application (2013-2018)
        • 9.4.1 Middle East and Africa Equine Pharmaceuticals and Supplements Sales and Sales Share by Application (2013-2018)
        • 9.4.2 Middle East and Africa Equine Pharmaceuticals and Supplements Revenue and Revenue Share by Application (2013-2018)

      10 Global Equine Pharmaceuticals and Supplements Market Segment by Type

      • 10.1 Global Equine Pharmaceuticals and Supplements Sales, Revenue and Market Share by Type (2013-2018)
        • 10.1.1 Global Equine Pharmaceuticals and Supplements Sales and Market Share by Type (2013-2018)
        • 10.1.2 Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Type (2013-2018)
      • 10.2 Pharmaceuticals Sales Growth and Price
        • 10.2.1 Global Pharmaceuticals Sales Growth (2013-2018)
        • 10.2.2 Global Pharmaceuticals Price (2013-2018)
      • 10.3 Supplements Sales Growth and Price
        • 10.3.1 Global Supplements Sales Growth (2013-2018)
        • 10.3.2 Global Supplements Price (2013-2018)

      11 Global Equine Pharmaceuticals and Supplements Market Segment by Application

      • 11.1 Global Equine Pharmaceuticals and Supplements Sales Market Share by Application (2013-2018)
      • 11.2 Veterinary Hospitals Sales Growth (2013-2018)
      • 11.3 Drug Stores Sales Growth (2013-2018)
      • 11.4 Others Sales Growth (2013-2018)

      12 Equine Pharmaceuticals and Supplements Market Forecast (2018-2023)

      • 12.1 Global Equine Pharmaceuticals and Supplements Sales, Revenue and Growth Rate (2018-2023)
      • 12.2 Equine Pharmaceuticals and Supplements Market Forecast by Regions (2018-2023)
        • 12.2.1 North America Equine Pharmaceuticals and Supplements Market Forecast (2018-2023)
        • 12.2.2 Europe Equine Pharmaceuticals and Supplements Market Forecast (2018-2023)
        • 12.2.3 Asia-Pacific Equine Pharmaceuticals and Supplements Market Forecast (2018-2023)
        • 12.2.4 South America Equine Pharmaceuticals and Supplements Market Forecast (2018-2023)
        • 12.2.5 Middle East and Africa Equine Pharmaceuticals and Supplements Market Forecast (2018-2023)
      • 12.3 Equine Pharmaceuticals and Supplements Market Forecast by Type (2018-2023)
        • 12.3.1 Global Equine Pharmaceuticals and Supplements Sales Forecast by Type (2018-2023)
        • 12.3.2 Global Equine Pharmaceuticals and Supplements Market Share Forecast by Type (2018-2023)
      • 12.4 Equine Pharmaceuticals and Supplements Market Forecast by Application (2018-2023)
        • 12.4.1 Global Equine Pharmaceuticals and Supplements Sales Forecast by Application (2018-2023)
        • 12.4.2 Global Equine Pharmaceuticals and Supplements Market Share Forecast by Application (2018-2023)

      13 Sales Channel, Distributors, Traders and Dealers

      • 13.1 Sales Channel
        • 13.1.1 Direct Marketing
        • 13.1.2 Indirect Marketing
        • 13.1.3 Marketing Channel Future Trend
      • 13.2 Distributors, Traders and Dealers

      14 Research Findings and Conclusion

        15 Appendix

        • 15.1 Methodology

      Governments and various animal health institutions spread awareness about the need for good healthy diets and health supplements for the growth and healthy life of the horses among the horse breeders and trainers in various equine industries. Moreover, they provide information and awareness about the need for prevention of certain diseases and the remedy for some medical conditions. Increasing awareness about equine pharmaceuticals and supplements products is driving the growth of the global equine pharmaceuticals and supplements market. Demand for herbal digestive, feed, and energy supplements for horses are increasing due to the preference among horse breeders and trainers for natural products and it is expected to drive the growth of the pharmaceuticals and supplements market. The horseracing and equestrian sectors drive the demand for equine pharmaceutical products, as the health of the horses are very important for sustaining the growth of those sectors. Healthy horses in these sectors provide the impetus for the betting and gambling industries related to horse racing. Therefore, most of the trainers and breeders of horses adopt advanced pharmaceutical products for preventing illnesses and for healing the diseases, so that the horses are in good shape for the races.

      Scope of the Report:
      This report focuses on the Equine Pharmaceuticals and Supplements in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
      The worldwide market for Equine Pharmaceuticals and Supplements is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

      Market Segment by Manufacturers, this report covers
      Affymetrix
      Bayer Animal Health
      Boehringer Ingelheim
      Celltrion Inc
      Elanco Animal Health
      Merck Animal Health
      Merial
      Novartis Animal Health
      Vetoquinol
      Zoetis

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Pharmaceuticals
      Supplements

      Market Segment by Applications, can be divided into
      Veterinary Hospitals
      Drug Stores
      Others

      There are 15 Chapters to deeply display the global Equine Pharmaceuticals and Supplements market.
      Chapter 1, to describe Equine Pharmaceuticals and Supplements Introduction, product scope, market overview, market opportunities, market risk, market driving force;
      Chapter 2, to analyze the top manufacturers of Equine Pharmaceuticals and Supplements, with sales, revenue, and price of Equine Pharmaceuticals and Supplements, in 2016 and 2017;
      Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
      Chapter 4, to show the global market by regions, with sales, revenue and market share of Equine Pharmaceuticals and Supplements, for each region, from 2013 to 2018;
      Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
      Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
      Chapter 12, Equine Pharmaceuticals and Supplements market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
      Chapter 13, 14 and 15, to describe Equine Pharmaceuticals and Supplements sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

      Buy now